Eye Drops

Verify with FDA CVM →

32 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
32
Total Reports
4
Deaths Reported
1250.0%
Death Rate

Active Ingredients

Eye Drops

Administration Routes

UnknownOphthalmicIntraocularAuricular (Otic)

Species Affected

Dog 21
Cat 9
Human 2

Most Affected Breeds

Domestic Shorthair 7
Crossbred Canine/dog 3
Retriever - Labrador 3
Terrier - Boston 2
Dog (unknown) 2
Unknown 2
Collie - Border 1
Terrier - Rat 1
Shepherd Dog - Australian 1
Pug 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 6
Diarrhoea 5
Vomiting 5
Corneal ulcer 4
Anorexia 3
Ocular discharge 2
Behavioural disorder NOS 2
Weight loss 2
Eye disorder NOS (for photophobia see 'neurological') 2
Dry eye 2
Pruritus 2
Lack of efficacy (ectoparasite) - flea 2

Outcome Breakdown

Outcome Unknown
13 (40.6%)
Ongoing
10 (31.3%)
Recovered/Normal
5 (15.6%)
Euthanized
2 (6.3%)
Died
2 (6.3%)

Data Summary

Metric Value
Total adverse event reports 32
Reports involving death 4
Case-fatality rate (reported events) 1250.0%
Distinct species in reports 3
Distinct breeds in reports 19
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Eye Drops Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 32 adverse event reports referencing Eye Drops, including 4 reports in which the animal died — a 1250.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Eye Drops. Reported administration routes include Unknown, Ophthalmic, Intraocular, Auricular (Otic). These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Eye Drops reports are Dog (21 reports), Cat (9 reports), Human (2 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (7), Crossbred Canine/dog (3), Retriever - Labrador (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Eye Drops are Lethargy (see also Central nervous system depression in 'Neurological') (6), Diarrhoea (5), Vomiting (5), Corneal ulcer (4). Of the 32 reports with a coded outcome, Outcome Unknown is the leading category at 40.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Eye Drops.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial